0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Antifungal Drug Market Research Report 2020
Published Date: February 2020
|
Report Code: QYRE-Auto-11C1517
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Antifungal Drug Market Research Report 2020

Global Antifungal Drug Market Research Report 2020

Code: QYRE-Auto-11C1517
Report
February 2020
Pages:116
QYResearch
Description
Table of Content
Tables & Figures
This report focuses on Antifungal Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Antifungal Drug market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
    Asperqillus
    Alternaria
    Abbott Laboratories
    Pfizer
    Glaxosmithkline
    Bayer Healthcare
    Novartis
    Sanofi-Aventis
    Merck & Co.
    Kramer Laboratories
    Enzon Pharmaceuticals
    Gilead
Segment by Regions
    North America
    Europe
    China
    Japan
Segment by Type
    Echinocandins
    Azoles
    Ployenes
    Allylamines
Segment by Application
    Aspergillosis
    Dermatophytosis
    Candidiasis
Table of Contents
1 Antifungal Drug Market Overview
1.1 Product Overview and Scope of Antifungal Drug
1.2 Antifungal Drug Segment by Type
1.2.1 Global Antifungal Drug Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Echinocandins
1.2.3 Azoles
1.2.4 Ployenes
1.2.5 Allylamines
1.3 Antifungal Drug Segment by Application
1.3.1 Antifungal Drug Sales Comparison by Application: 2020 VS 2026
1.3.2 Aspergillosis
1.3.3 Dermatophytosis
1.3.4 Candidiasis
1.4 Global Antifungal Drug Market Size Estimates and Forecasts
1.4.1 Global Antifungal Drug Revenue 2015-2026
1.4.2 Global Antifungal Drug Sales 2015-2026
1.4.3 Antifungal Drug Market Size by Region: 2020 Versus 2026
2 Global Antifungal Drug Market Competition by Manufacturers
2.1 Global Antifungal Drug Sales Market Share by Manufacturers (2015-2020)
2.2 Global Antifungal Drug Revenue Share by Manufacturers (2015-2020)
2.3 Global Antifungal Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Antifungal Drug Manufacturing Sites, Area Served, Product Type
2.5 Antifungal Drug Market Competitive Situation and Trends
2.5.1 Antifungal Drug Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Antifungal Drug Players (Opinion Leaders)
3 Antifungal Drug Retrospective Market Scenario by Region
3.1 Global Antifungal Drug Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Antifungal Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Antifungal Drug Market Facts & Figures by Country
3.3.1 North America Antifungal Drug Sales by Country
3.3.2 North America Antifungal Drug Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Antifungal Drug Market Facts & Figures by Country
3.4.1 Europe Antifungal Drug Sales by Country
3.4.2 Europe Antifungal Drug Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Antifungal Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Antifungal Drug Sales by Region
3.5.2 Asia Pacific Antifungal Drug Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Antifungal Drug Market Facts & Figures by Country
3.6.1 Latin America Antifungal Drug Sales by Country
3.6.2 Latin America Antifungal Drug Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Antifungal Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Antifungal Drug Sales by Country
3.7.2 Middle East and Africa Antifungal Drug Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Antifungal Drug Historic Market Analysis by Type
4.1 Global Antifungal Drug Sales Market Share by Type (2015-2020)
4.2 Global Antifungal Drug Revenue Market Share by Type (2015-2020)
4.3 Global Antifungal Drug Price Market Share by Type (2015-2020)
4.4 Global Antifungal Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Antifungal Drug Historic Market Analysis by Application
5.1 Global Antifungal Drug Sales Market Share by Application (2015-2020)
5.2 Global Antifungal Drug Revenue Market Share by Application (2015-2020)
5.3 Global Antifungal Drug Price by Application (2015-2020)
6 Company Profiles and Key Figures in Antifungal Drug Business
6.1 Asperqillus
6.1.1 Corporation Information
6.1.2 Asperqillus Description, Business Overview and Total Revenue
6.1.3 Asperqillus Antifungal Drug Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Asperqillus Products Offered
6.1.5 Asperqillus Recent Development
6.2 Alternaria
6.2.1 Alternaria Antifungal Drug Production Sites and Area Served
6.2.2 Alternaria Description, Business Overview and Total Revenue
6.2.3 Alternaria Antifungal Drug Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Alternaria Products Offered
6.2.5 Alternaria Recent Development
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Antifungal Drug Production Sites and Area Served
6.3.2 Abbott Laboratories Description, Business Overview and Total Revenue
6.3.3 Abbott Laboratories Antifungal Drug Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Abbott Laboratories Products Offered
6.3.5 Abbott Laboratories Recent Development
6.4 Pfizer
6.4.1 Pfizer Antifungal Drug Production Sites and Area Served
6.4.2 Pfizer Description, Business Overview and Total Revenue
6.4.3 Pfizer Antifungal Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Pfizer Products Offered
6.4.5 Pfizer Recent Development
6.5 Glaxosmithkline
6.5.1 Glaxosmithkline Antifungal Drug Production Sites and Area Served
6.5.2 Glaxosmithkline Description, Business Overview and Total Revenue
6.5.3 Glaxosmithkline Antifungal Drug Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Glaxosmithkline Products Offered
6.5.5 Glaxosmithkline Recent Development
6.6 Bayer Healthcare
6.6.1 Bayer Healthcare Antifungal Drug Production Sites and Area Served
6.6.2 Bayer Healthcare Description, Business Overview and Total Revenue
6.6.3 Bayer Healthcare Antifungal Drug Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Bayer Healthcare Products Offered
6.6.5 Bayer Healthcare Recent Development
6.7 Novartis
6.6.1 Novartis Antifungal Drug Production Sites and Area Served
6.6.2 Novartis Description, Business Overview and Total Revenue
6.6.3 Novartis Antifungal Drug Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Novartis Products Offered
6.7.5 Novartis Recent Development
6.8 Sanofi-Aventis
6.8.1 Sanofi-Aventis Antifungal Drug Production Sites and Area Served
6.8.2 Sanofi-Aventis Description, Business Overview and Total Revenue
6.8.3 Sanofi-Aventis Antifungal Drug Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Sanofi-Aventis Products Offered
6.8.5 Sanofi-Aventis Recent Development
6.9 Merck & Co.
6.9.1 Merck & Co. Antifungal Drug Production Sites and Area Served
6.9.2 Merck & Co. Description, Business Overview and Total Revenue
6.9.3 Merck & Co. Antifungal Drug Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Merck & Co. Products Offered
6.9.5 Merck & Co. Recent Development
6.10 Kramer Laboratories
6.10.1 Kramer Laboratories Antifungal Drug Production Sites and Area Served
6.10.2 Kramer Laboratories Description, Business Overview and Total Revenue
6.10.3 Kramer Laboratories Antifungal Drug Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Kramer Laboratories Products Offered
6.10.5 Kramer Laboratories Recent Development
6.11 Enzon Pharmaceuticals
6.11.1 Enzon Pharmaceuticals Antifungal Drug Production Sites and Area Served
6.11.2 Enzon Pharmaceuticals Antifungal Drug Description, Business Overview and Total Revenue
6.11.3 Enzon Pharmaceuticals Antifungal Drug Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Enzon Pharmaceuticals Products Offered
6.11.5 Enzon Pharmaceuticals Recent Development
6.12 Gilead
6.12.1 Gilead Antifungal Drug Production Sites and Area Served
6.12.2 Gilead Antifungal Drug Description, Business Overview and Total Revenue
6.12.3 Gilead Antifungal Drug Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Gilead Products Offered
6.12.5 Gilead Recent Development
7 Antifungal Drug Manufacturing Cost Analysis
7.1 Antifungal Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Antifungal Drug
7.4 Antifungal Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Antifungal Drug Distributors List
8.3 Antifungal Drug Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Antifungal Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Antifungal Drug by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Antifungal Drug by Type (2021-2026)
10.2 Antifungal Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Antifungal Drug by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Antifungal Drug by Application (2021-2026)
10.3 Antifungal Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Antifungal Drug by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Antifungal Drug by Region (2021-2026)
10.4 North America Antifungal Drug Estimates and Projections (2021-2026)
10.5 Europe Antifungal Drug Estimates and Projections (2021-2026)
10.6 Asia Pacific Antifungal Drug Estimates and Projections (2021-2026)
10.7 Latin America Antifungal Drug Estimates and Projections (2021-2026)
10.8 Middle East and Africa Antifungal Drug Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
    Table 1. Global Antifungal Drug Sales (K Units) Growth Rate Comparison by Type (2015-2026)
    Table 2. Global Antifungal Drug Sales (K Units) Comparison by Application: 2020 VS 2026
    Table 3. Global Antifungal Drug Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
    Table 4. Global Key Antifungal Drug Manufacturers Covered in This Study
    Table 5. Global Antifungal Drug Sales (K Units) by Manufacturers (2015-2020)
    Table 6. Global Antifungal Drug Sales Share by Manufacturers (2015-2020)
    Table 7. Global Antifungal Drug Revenue (Million USD) by Manufacturers (2015-2020)
    Table 8. Global Antifungal Drug Revenue Share by Manufacturers (2015-2020)
    Table 9. Global Market Antifungal Drug Average Price (USD/Unit) of Key Manufacturers (2015-2020)
    Table 10. Manufacturers Antifungal Drug Sales Sites and Area Served
    Table 11. Manufacturers Antifungal Drug Product Types
    Table 12. Global Antifungal Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Antifungal Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antifungal Drug as of 2019)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Main Points Interviewed from Key Antifungal Drug Players
    Table 16. Global Antifungal Drug Sales (K Units) by Region (2015-2020)
    Table 17. Global Antifungal Drug Sales Market Share by Region (2015-2020)
    Table 18. Global Antifungal Drug Revenue (Million US$) by Region (2015-2020)
    Table 19. Global Antifungal Drug Revenue Market Share by Region (2015-2020)
    Table 20. North America Antifungal Drug Sales by Country (2015-2020) (K Units)
    Table 21. North America Antifungal Drug Sales Market Share by Country (2015-2020)
    Table 22. North America Antifungal Drug Revenue by Country (2015-2020) (US$ Million)
    Table 23. North America Antifungal Drug Revenue Market Share by Country (2015-2020)
    Table 24. Europe Antifungal Drug Sales by Country (2015-2020) (K Units)
    Table 25. Europe Antifungal Drug Sales Market Share by Country (2015-2020)
    Table 26. Europe Antifungal Drug Revenue by Country (2015-2020) (US$ Million)
    Table 27. Europe Antifungal Drug Revenue Market Share by Country (2015-2020)
    Table 28. Asia Pacific Antifungal Drug Sales by Region (2015-2020) (K Units)
    Table 29. Asia Pacific Antifungal Drug Sales Market Share by Region (2015-2020)
    Table 30. Asia Pacific Antifungal Drug Revenue by Region (2015-2020) (US$ Million)
    Table 31. Asia Pacific Antifungal Drug Revenue Market Share by Region (2015-2020)
    Table 32. Latin America Antifungal Drug Sales by Country (2015-2020) (K Units)
    Table 33. Latin America Antifungal Drug Sales Market Share by Country (2015-2020)
    Table 34. Latin America Antifungal Drug Revenue by Country (2015-2020) (US$ Million)
    Table 35. Latin America Antifungal Drug Revenue Market Share by Country (2015-2020)
    Table 36. Middle East and Africa Antifungal Drug Sales by Country (2015-2020) (K Units)
    Table 37. Middle East and Africa Antifungal Drug Sales Market Share by Country (2015-2020)
    Table 38. Middle East and Africa Antifungal Drug Revenue by Country (2015-2020) (US$ Million)
    Table 39. Middle East and Africa Antifungal Drug Revenue Market Share by Country (2015-2020)
    Table 40. Global Antifungal Drug Sales (K Units) by Type (2015-2020)
    Table 41. Global Antifungal Drug Sales Share by Type (2015-2020)
    Table 42. Global Antifungal Drug Revenue (Million US$) by Type (2015-2020)
    Table 43. Global Antifungal Drug Revenue Share by Type (2015-2020)
    Table 44. Global Antifungal Drug Price (USD/Unit) by Type (2015-2020)
    Table 45. Global Antifungal Drug Sales (K Units) by Application (2015-2020)
    Table 46. Global Antifungal Drug Sales Market Share by Application (2015-2020)
    Table 47. Global Antifungal Drug Sales Growth Rate by Application (2015-2020)
    Table 48. Asperqillus Antifungal Drug Corporation Information
    Table 49. Asperqillus Description and Business Overview
    Table 50. Asperqillus Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 51. Asperqillus Main Product
    Table 52. Asperqillus Recent Development
    Table 53. Alternaria Antifungal Drug Corporation Information
    Table 54. Alternaria Corporation Information
    Table 55. Alternaria Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 56. Alternaria Main Product
    Table 57. Alternaria Recent Development
    Table 58. Abbott Laboratories Antifungal Drug Corporation Information
    Table 59. Abbott Laboratories Corporation Information
    Table 60. Abbott Laboratories Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 61. Abbott Laboratories Main Product
    Table 62. Abbott Laboratories Recent Development
    Table 63. Pfizer Antifungal Drug Corporation Information
    Table 64. Pfizer Corporation Information
    Table 65. Pfizer Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 66. Pfizer Main Product
    Table 67. Pfizer Recent Development
    Table 68. Glaxosmithkline Antifungal Drug Corporation Information
    Table 69. Glaxosmithkline Corporation Information
    Table 70. Glaxosmithkline Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 71. Glaxosmithkline Main Product
    Table 72. Glaxosmithkline Recent Development
    Table 73. Bayer Healthcare Antifungal Drug Corporation Information
    Table 74. Bayer Healthcare Corporation Information
    Table 75. Bayer Healthcare Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 76. Bayer Healthcare Main Product
    Table 77. Bayer Healthcare Recent Development
    Table 78. Novartis Antifungal Drug Corporation Information
    Table 79. Novartis Corporation Information
    Table 80. Novartis Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 81. Novartis Main Product
    Table 82. Novartis Recent Development
    Table 83. Sanofi-Aventis Antifungal Drug Corporation Information
    Table 84. Sanofi-Aventis Corporation Information
    Table 85. Sanofi-Aventis Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 86. Sanofi-Aventis Main Product
    Table 87. Sanofi-Aventis Recent Development
    Table 88. Merck & Co. Antifungal Drug Corporation Information
    Table 89. Merck & Co. Corporation Information
    Table 90. Merck & Co. Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 91. Merck & Co. Main Product
    Table 92. Merck & Co. Recent Development
    Table 93. Kramer Laboratories Antifungal Drug Corporation Information
    Table 94. Kramer Laboratories Corporation Information
    Table 95. Kramer Laboratories Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 96. Kramer Laboratories Main Product
    Table 97. Kramer Laboratories Recent Development
    Table 98. Enzon Pharmaceuticals Antifungal Drug Corporation Information
    Table 99. Enzon Pharmaceuticals Corporation Information
    Table 100. Enzon Pharmaceuticals Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 101. Enzon Pharmaceuticals Main Product
    Table 102. Enzon Pharmaceuticals Recent Development
    Table 103. Gilead Antifungal Drug Corporation Information
    Table 104. Gilead Corporation Information
    Table 105. Gilead Antifungal Drug Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
    Table 106. Gilead Main Product
    Table 107. Gilead Recent Development
    Table 108. Sales Base and Market Concentration Rate of Raw Material
    Table 109. Key Suppliers of Raw Materials
    Table 110. Antifungal Drug Distributors List
    Table 111. Antifungal Drug Customers List
    Table 112. Market Key Trends
    Table 113. Key Opportunities and Drivers: Impact Analysis (2021-2026)
    Table 114. Key Challenges
    Table 115. Global Antifungal Drug Sales (K Units) Forecast by Type (2021-2026)
    Table 116. Global Antifungal Drug Sales Market Share Forecast by Type (2021-2026)
    Table 117. Global Antifungal Drug Revenue (Million US$) Forecast by Type (2021-2026)
    Table 118. Global Antifungal Drug Revenue (Million US$) Market Share Forecast by Type (2021-2026)
    Table 119. Global Antifungal Drug Sales (K Units) Forecast by Application (2021-2026)
    Table 120. Global Antifungal Drug Revenue (Million US$) Forecast by Application (2021-2026)
    Table 121. Global Antifungal Drug Sales (K Units) Forecast by Region (2021-2026)
    Table 122. Global Antifungal Drug Sales Market Share Forecast by Region (2021-2026)
    Table 123. Global Antifungal Drug Revenue Forecast by Region (2021-2026) (US$ Million)
    Table 124. Global Antifungal Drug Revenue Market Share Forecast by Region (2021-2026)
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
List of Figures
    Figure 1. Picture of Antifungal Drug
    Figure 2. Global Antifungal Drug Sales Market Share by Type: 2020 VS 2026
    Figure 3. Echinocandins Product Picture
    Figure 4. Azoles Product Picture
    Figure 5. Ployenes Product Picture
    Figure 6. Allylamines Product Picture
    Figure 7. Global Antifungal Drug Consumption Market Share by Application: 2020 VS 2026
    Figure 8. Aspergillosis
    Figure 9. Dermatophytosis
    Figure 10. Candidiasis
    Figure 11. Global Antifungal Drug Market Size 2015-2026 (US$ Million)
    Figure 12. Global Antifungal Drug Sales Capacity (K Units) (2015-2026)
    Figure 13. Global Antifungal Drug Market Size Market Share by Region: 2020 Versus 2026
    Figure 14. Antifungal Drug Sales Share by Manufacturers in 2020
    Figure 15. Global Antifungal Drug Revenue Share by Manufacturers in 2019
    Figure 16. The Global 5 and 10 Largest Players: Market Share by Antifungal Drug Revenue in 2019
    Figure 17. Antifungal Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
    Figure 18. Global Antifungal Drug Sales Market Share by Region (2015-2020)
    Figure 19. Global Antifungal Drug Sales Market Share by Region in 2019
    Figure 20. Global Antifungal Drug Revenue Market Share by Region (2015-2020)
    Figure 21. Global Antifungal Drug Revenue Market Share by Region in 2019
    Figure 22. North America Antifungal Drug Sales Market Share by Country in 2019
    Figure 23. North America Antifungal Drug Revenue Market Share by Country in 2019
    Figure 24. U.S. Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 25. U.S. Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 26. Canada Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 27. Canada Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 28. Europe Antifungal Drug Sales Market Share by Country in 2019
    Figure 29. Europe Antifungal Drug Revenue Market Share by Country in 2019
    Figure 30. Germany Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 31. Germany Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 32. France Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 33. France Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 34. U.K. Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 35. U.K. Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 36. Italy Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 37. Italy Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 38. Russia Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 39. Russia Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 40. Asia Pacific Antifungal Drug Sales Market Share by Region in 2019
    Figure 41. Asia Pacific Antifungal Drug Revenue Market Share by Region in 2019
    Figure 42. China Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 43. China Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 44. Japan Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 45. Japan Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 46. South Korea Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 47. South Korea Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 48. India Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 49. India Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 50. Australia Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 51. Australia Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 52. Taiwan Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 53. Taiwan Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 54. Indonesia Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 55. Indonesia Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 56. Thailand Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 57. Thailand Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 58. Malaysia Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 59. Malaysia Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 60. Philippines Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 61. Philippines Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 62. Vietnam Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 63. Vietnam Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 64. Latin America Antifungal Drug Sales Market Share by Country in 2019
    Figure 65. Latin America Antifungal Drug Revenue Market Share by Country in 2019
    Figure 66. Mexico Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 67. Mexico Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 68. Brazil Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 69. Brazil Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 70. Argentina Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 71. Argentina Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 72. Middle East and Africa Antifungal Drug Sales Market Share by Country in 2019
    Figure 73. Middle East and Africa Antifungal Drug Revenue Market Share by Country in 2019
    Figure 74. Turkey Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 75. Turkey Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 76. Saudi Arabia Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 77. Saudi Arabia Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 78. U.A.E Antifungal Drug Sales Growth Rate (2015-2020) (K Units)
    Figure 79. U.A.E Antifungal Drug Revenue Growth Rate (2015-2020) (US$ Million)
    Figure 80. Sales Market Share of Antifungal Drug by Type (2015-2020)
    Figure 81. Sales Market Share of Antifungal Drug by Type in 2019
    Figure 82. Revenue Share of Antifungal Drug by Type (2015-2020)
    Figure 83. Revenue Market Share of Antifungal Drug by Type in 2019
    Figure 84. Global Antifungal Drug Sales Growth by Type (2015-2020) (K Units)
    Figure 85. Global Antifungal Drug Sales Market Share by Application (2015-2020)
    Figure 86. Global Antifungal Drug Sales Market Share by Application in 2019
    Figure 87. Global Revenue Share of Antifungal Drug by Application (2015-2020)
    Figure 88. Global Revenue Share of Antifungal Drug by Application in 2020
    Figure 89. Asperqillus Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 90. Alternaria Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 91. Abbott Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 92. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 93. Glaxosmithkline Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 94. Bayer Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 95. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 96. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 97. Merck & Co. Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 98. Kramer Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 99. Enzon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 100. Gilead Total Revenue (US$ Million): 2019 Compared with 2018
    Figure 101. Price Trend of Key Raw Materials
    Figure 102. Manufacturing Cost Structure of Antifungal Drug
    Figure 103. Manufacturing Process Analysis of Antifungal Drug
    Figure 104. Antifungal Drug Industrial Chain Analysis
    Figure 105. Channels of Distribution
    Figure 106. Distributors Profiles
    Figure 107. Porter's Five Forces Analysis
    Figure 108. North America Antifungal Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
    Figure 109. North America Antifungal Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 110. Europe Antifungal Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
    Figure 111. Europe Antifungal Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 112. Latin America Antifungal Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
    Figure 113. Latin America Antifungal Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 114. Middle East and Africa Antifungal Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
    Figure 115. Middle East and Africa Antifungal Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 116. Asia Pacific Antifungal Drug Sales (K Units) and Growth Rate Forecast (2021-2026)
    Figure 117. Asia Pacific Antifungal Drug Revenue (Million US$) and Growth Rate Forecast (2021-2026)
    Figure 118. Bottom-up and Top-down Approaches for This Report
    Figure 119. Data Triangulation
    Figure 120. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmaceutical Aseptic Fill and Finish CMO Service Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-1R8980
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Quizartinib Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-3Q8625
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Octreotide Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-3X12361
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Veterinary Anesthesia Vaporizers Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-35M13226
Tue Feb 20 00:00:00 UTC 2024

Add to Cart